Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Healius Limited (AU:HLS)
ASX:HLS
Holding AU:HLS?
Track your performance easily
HLS Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$1.08 - AU$2.25
Previous CloseAU$1.67
Volume1.02M
Average Volume (3M)2.31M
Market Cap
AU$1.21B
Enterprise ValueAU$2.91B
Total Cash (Recent Filing)AU$81.30M
Total Debt (Recent Filing)AU$1.78B
Price to Earnings (P/E)―
Beta1.18
Next Earnings
Feb 25, 2025EPS Estimate
<AU$0.01Last Dividend Ex-Date
Sep 07, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-1.08
Shares OutstandingN/A
10 Day Avg. Volume2,085,452
30 Day Avg. Volume2,314,466
Standard Deviation0.11
R-Squared0.25
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.95
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.46Price Target Upside-9.64% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering8
Healius Limited News
PremiumCompany Announcements
Healius Limited Welcomes Major New Stakeholder
PremiumCompany Announcements
Healius Limited Champions Corporate Governance
PremiumCompany Announcements
Healius Confirms Full Governance Compliance
PremiumCompany Announcements
Healius Limited Unveils Comprehensive 2024 Annual Report
PremiumCompany Announcements
Healius Limited Stake Reduced by Perpetual LimitedPremiumCompany Announcements
State Street Ends Substantial Holding in Healius
PremiumCompany Announcements
Spheria Asset Management Exits Healius StakePremiumCompany Announcements
Healius Limited Seeks Quotation for New SecuritiesOptions Prices
Currently, No data available
---
Ownership Overview
3.04% Insiders
5.28% Mutual Funds
3.52% Other Institutional Investors
88.16% Public Companies and
Individual Investors
HLS FAQ
What was Healius Limited’s price range in the past 12 months?
Healius Limited lowest share price was AU$1.08 and its highest was AU$2.25 in the past 12 months.
What is Healius Limited’s market cap?
Currently, no data Available
When is Healius Limited’s upcoming earnings report date?
Healius Limited’s upcoming earnings report date is Feb 25, 2025 which is in 157 days.
How were Healius Limited’s earnings last quarter?
Healius Limited released its earnings results on Aug 20, 2024. The company reported AU$0.013 earnings per share for the quarter, beating the consensus estimate of AU$0.011 by AU$0.002.
Is Healius Limited overvalued?
According to Wall Street analysts Healius Limited’s price is currently Overvalued.
Does Healius Limited pay dividends?
Healius Limited pays a Notavailable dividend of AU$0.06 which represents an annual dividend yield of N/A. See more information on Healius Limited dividends here
What is Healius Limited’s EPS estimate?
Healius Limited’s EPS estimate is <AU$0.01.
How many shares outstanding does Healius Limited have?
Healius Limited has 726,132,800 shares outstanding.
What happened to Healius Limited’s price movement after its last earnings report?
Healius Limited reported an EPS of AU$0.013 in its last earnings report, beating expectations of AU$0.011. Following the earnings report the stock price went up 12.925%.
Which hedge fund is a major shareholder of Healius Limited?
Currently, no hedge funds are holding shares in AU:HLS
---
Healius Limited Stock Smart Score
Company Description
Healius Limited
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Medical Centres and Imaging. The Pathology segment provides pathology services. The Medical Centres segment provides services and facilities to general practitioners, specialists, dentists, IVF specialists and other healthcare professionals operating in the bulk billing and private billing sectors. The Imaging segment provides imaging and scanning services from stand-alone imaging sites, hospitals and from within the consolidated entity's medical centres. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leichhardt, Australia.
---
HLS Stock 12 Month Forecast
Average Price Target
AU$1.46
▼(-9.64% Downside)
Technical Analysis
nebag ag
―
AURELIUS Equity Opportunities SE & Co. KGaA
―
Capitol Health Limited
―
Healius Limited
―
Rhythm Biosciences Ltd.
―
Best Analysts Covering HLS
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
+20.10%
reiterated a sell rating 26 days ago
Copying Steven Wheen's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +20.10% per trade.
---